a

We believe that the most advanced medicines treatments approved worldwide, should be available to everyone as quickly as possible, no matter where they are located.



Email customer service

customersupport@50bestpharma.com

Address

3 Shenton Way # 16-08.
Shenton House, Singapore 068805

0 items USD 0.00
  • No products in the cart.
6

Brand Medicines

Home/Brand Medicines (Page 4)

Showing 37-48 of 129 results

  • USD 3,268.30
    75 MG 21 CAP
    Active principle:

    PALBOCICLIB


    Laboratory:

    PFIZER


    Approved by:

    ANMAT, ANVISA, COFEPRIS, EMA, ...


    USD 3,268.30 Add to Cart
  • USD 3,268.30
    100 MG 21 CAP
    Active principle:

    PALBOCICLIB


    Laboratory:

    PFIZER


    Approved by:

    ANMAT, ANVISA, COFEPRIS, EMA, ...


    USD 3,268.30 Add to Cart
  • USD 3,268.30
    125 MG 21 CAP
    Active principle:

    PALBOCICLIB


    Laboratory:

    PFIZER


    Approved by:

    ANMAT, ANVISA, COFEPRIS, EMA, ...


    USD 3,268.30 Add to Cart
  • USD 1,699.52
    120 MG / 2.4 ML VIAL
    Active principle:

    DURVALUMAB


    Laboratory:

    ASTRA ZENECA


    Approved by:

    ANVISA, FDA


    USD 1,699.52 Add to Cart
  • USD 6,340.50
    500 MG / 10 ML VIAL
    Active principle:

    DURVALUMAB


    Laboratory:

    ASTRA ZENECA


    Approved by:

    ANVISA, FDA


    USD 6,340.50 Add to Cart
  • 10 MG 100 CAP
    Active principle:

    IBUDILAST


    Laboratory:

    KYORIN


    Approved by:

    PMDA


  • 10 MG 500 CAP
    Active principle:

    IBUDILAST


    Laboratory:

    KYORIN


    Approved by:

    PMDA


  • 10 MG 1000 CAP
    Active principle:

    IBUDILAST


    Laboratory:

    KYORIN


    Approved by:

    PMDA


  • 10 MG 2100 CAP
    Active principle:

    IBUDILAST


    Laboratory:

    KYORIN


    Approved by:

    PMDA


  • USD 1,928.30
    150 MG / 1.14 ML 2 PF SYR
    Active principle:

    SARILUMAB


    Laboratory:

    SANOFI


    Approved by:

    ANMAT, EMA, FDA


    USD 1,928.30 Add to Cart
  • USD 1,928.30
    200 MG / 1.14 ML 2 PF SYR
    Active principle:

    SARILUMAB


    Laboratory:

    SANOFI


    Approved by:

    ANMAT, EMA, FDA


    USD 1,928.30 Add to Cart
  • USD 3,791.22
    100 MG / 4 ML VIAL
    Active principle:

    PEMBROLIZUMAB


    Laboratory:

    MERCK


    Approved by:

    ANMAT, ANVISA, COFEPRIS, EMA, ...


    USD 3,791.22 Add to Cart

This website uses cookies

Cookies are unique identifiers that we transfer to your device to enable our systems to recognize your device and to provide communication features. Your access to www.50bestpharma.com signifies your consent to and agreement with the terms contained here in. You can confet your computer to disabel the cookies installation.